These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 20808846)

  • 21. TNF receptor signaling contributes to chemokine secretion, inflammation, and respiratory deficits during Pneumocystis pneumonia.
    Wright TW; Pryhuber GS; Chess PR; Wang Z; Notter RH; Gigliotti F
    J Immunol; 2004 Feb; 172(4):2511-21. PubMed ID: 14764724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of host immune responses and a potential function of Trem2
    Yang HQ; Sun H; Li K; Shao MM; Zhai K; Tong ZH
    Respir Res; 2024 Feb; 25(1):72. PubMed ID: 38317180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microarray studies on effects of Pneumocystis carinii infection on global gene expression in alveolar macrophages.
    Cheng BH; Liu Y; Xuei X; Liao CP; Lu D; Lasbury ME; Durant PJ; Lee CH
    BMC Microbiol; 2010 Apr; 10():103. PubMed ID: 20377877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model.
    Shellito JE; Kolls JK; Olariu R; Beck JM
    J Infect Dis; 1996 Feb; 173(2):432-9. PubMed ID: 8568306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective innate immunity against
    Mousso T; Pollock SJ; Inzerillo PC; Gigliotti F; Wright TW
    Infect Immun; 2024 Oct; 92(10):e0022224. PubMed ID: 39150267
    [No Abstract]   [Full Text] [Related]  

  • 26. Pneumocystis carinii induction of tumor necrosis factor-alpha by alveolar macrophages: modulation by pentamidine isethionate.
    Corsini E; Dykstra C; Craig WA; Tidwell RR; Rosenthal GJ
    Immunol Lett; 1992 Dec; 34(3):303-8. PubMed ID: 1487315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated pulmonary macrophages are insufficient for resistance against Pneumocystis carinii.
    Hanano R; Reifenberg K; Kaufmann SH
    Infect Immun; 1998 Jan; 66(1):305-14. PubMed ID: 9423872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dectin-2 Is a C-Type Lectin Receptor that Recognizes Pneumocystis and Participates in Innate Immune Responses.
    Kottom TJ; Hebrink DM; Jenson PE; Marsolek PL; Wüthrich M; Wang H; Klein B; Yamasaki S; Limper AH
    Am J Respir Cell Mol Biol; 2018 Feb; 58(2):232-240. PubMed ID: 28886250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymopoietic and bone marrow response to murine Pneumocystis pneumonia.
    Shi X; Zhang P; Sempowski GD; Shellito JE
    Infect Immun; 2011 May; 79(5):2031-42. PubMed ID: 21343353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts.
    Lasbury ME; Tang X; Durant PJ; Lee CH
    Infect Immun; 2003 Sep; 71(9):4943-52. PubMed ID: 12933836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-12 and host defense against murine Pneumocystis pneumonia.
    Ruan S; McKinley L; Zheng M; Rudner X; D'Souza A; Kolls JK; Shellito JE
    Infect Immun; 2008 May; 76(5):2130-7. PubMed ID: 18332204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a distinct host response profile to Pneumocystis murina asci during clearance of pneumocystis pneumonia.
    Linke MJ; Ashbaugh A; Collins MS; Lynch K; Cushion MT
    Infect Immun; 2013 Mar; 81(3):984-95. PubMed ID: 23319554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dectin immunoadhesins and pneumocystis pneumonia.
    Ricks DM; Chen K; Zheng M; Steele C; Kolls JK
    Infect Immun; 2013 Sep; 81(9):3451-62. PubMed ID: 23836814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of sulfasalazine for the prevention of Pneumocystis pneumonia in patients with rheumatoid arthritis: A multicentric self-controlled case series study.
    Nunokawa T; Chinen N; Shimada K; Kimura M; Tateishi M; Chen FY; Setoguchi K; Sugihara M
    J Infect Chemother; 2023 Feb; 29(2):193-197. PubMed ID: 36334836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammatory responses to Pneumocystis carinii in mice selectively depleted of helper T lymphocytes.
    Beck JM; Warnock ML; Curtis JL; Sniezek MJ; Arraj-Peffer SM; Kaltreider HB; Shellito JE
    Am J Respir Cell Mol Biol; 1991 Aug; 5(2):186-97. PubMed ID: 1679991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Granulocyte-macrophage colony-stimulating factor in the innate immune response to Pneumocystis carinii pneumonia in mice.
    Paine R; Preston AM; Wilcoxen S; Jin H; Siu BB; Morris SB; Reed JA; Ross G; Whitsett JA; Beck JM
    J Immunol; 2000 Mar; 164(5):2602-9. PubMed ID: 10679099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steady-state effects of vitronectin and fibronectin on the binding, uptake, and degradation of Pneumocystis carinii in rat alveolar macrophages.
    Hoyte JS; Standing JE; Limper AH
    Inflammation; 1997 Jun; 21(3):335-45. PubMed ID: 9246575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice.
    Wiley JA; Harmsen AG
    J Immunol; 1995 Oct; 155(7):3525-9. PubMed ID: 7561048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-CD3 antibody decreases inflammation and improves outcome in a murine model of Pneumocystis pneumonia.
    Bhagwat SP; Wright TW; Gigliotti F
    J Immunol; 2010 Jan; 184(1):497-502. PubMed ID: 19949093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MyD88 signaling regulates both host defense and immunopathogenesis during pneumocystis infection.
    Bello-Irizarry SN; Wang J; Johnston CJ; Gigliotti F; Wright TW
    J Immunol; 2014 Jan; 192(1):282-92. PubMed ID: 24293628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.